Natus Medical (BABY)
Natus Medical Interest Expense: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BABY Interest Expense Rankings
| Overall | 99th percentile | 24 of 4657 |
| Sector | 99th percentile | 3 of 525 in Healthcare |
| Industry | 97th percentile | 2 of 79 in Medical Appliances & Equipment |
BABY Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 0.00 | Jun 2007 |
| Average | 0.00 |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
You may also be interested in these BABY related companies
BABY News
Got out $GT at 12.15. +1.05. Jumped in $BABY few days ago at 11. Holding $HD since 50.6. Will be osting more great picks as they set up.
about 30 days ago by traderNC
about 30 days ago by traderNC
Listen to $BABY Q1 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/3WtX
about 31 days ago by earningscast
about 31 days ago by earningscast
Listen to $BABY CareFusion to Sell Neurodiagnostic Business to Natus Medical for - live at 09:00 AM, ondemand after - http://stks.co/3SYD
about 34 days ago by earningscast
about 34 days ago by earningscast
Carefusion (CFN) to Sell Natus Medical (BABY) Its Neurodiagnostic Unit for $58M; BABY Shares Halted
Apr 23, 7:05AM Street Insider
Apr 23, 7:05AM Street Insider
CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
Apr 23, 7:00AM PR Newswire
Apr 23, 7:00AM PR Newswire
Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26
Apr 17, 7:00AM Business Wire
Apr 17, 7:00AM Business Wire
$BABY http://stks.co/2tg0 would like some consolidation on the intraday chart before a breakout... long setup
about 72 days ago by stt2318
about 72 days ago by stt2318
Listen to $BABY Q4 2011 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2avH
about 89 days ago by earningscast
about 89 days ago by earningscast
UPDATE: Natus Medical Posts Weaker-Than-Expected Q4 Profit, Issues Downbeat Q1 Forecast
Feb 28, 9:34AM Benzinga
Feb 28, 9:34AM Benzinga
Natus Medical, Inc. (BABY) Misses Q4 EPS by 1c, Offers Q1 and FY12 Outlook
Feb 28, 7:08AM Street Insider
Feb 28, 7:08AM Street Insider
Natus Medical to Hold 2011 Fourth Quarter Financial Results Conference Call on February 28
Feb 21, 3:04PM Business Wire
Feb 21, 3:04PM Business Wire
$BABY - Highest close since Aug 2011 with volume perking???? http://chart.ly/dp97jg4
about 131 days ago by exkapie
about 131 days ago by exkapie
Natus Medical Announces 2012 Annual and First Quarter Financial Guidance
Jan 09, 7:00AM Business Wire
Jan 09, 7:00AM Business Wire
$BABY http://stks.co/1ouh Go BABY Go! Real nice "W-A Pattern. MACD above 0 Line. Nice trend. Prior resistance now support.
about 141 days ago by Fibline
about 141 days ago by Fibline
$BABY http://stks.co/1W0o Long setup: Tight price action & RSI flashed into higher high yesterday. Over 8.62
about 166 days ago by ToddinFL
about 166 days ago by ToddinFL
Natus Medical, Inc. (BABY) Reports In-Line Q3 EPS; Guides Q4, FY11 EPS ,Revs
Oct 27, 8:18AM Street Insider
Oct 27, 8:18AM Street Insider
$BABY prelim. Q3 sales $51.5M, down from $58M previously, vs. cons. $57.88M; sees Q4 adj-EPS 15c, down from prior 19-20c, vs. cons. 19c
about 231 days ago by Street_Insider
about 231 days ago by Street_Insider
$SQNM trisomy21 test in newspapers all over europe http://stks.co/61B http://stks.co/61C $ILMN $LIVE $CALP $BABY
about 264 days ago by biotech
about 264 days ago by biotech
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BABY | 11.22 | +0.02 | +0.18% | 330.32M |
| AXP | 55.81 | -0.53 | -0.94% | 65.20B |
| AXN | 0.32 | -0.02 | -7.11% | 15.81M |
| AXL | 9.32 | -0.09 | -0.96% | 698.81M |
| AXK | 2.73 | -0.03 | -1.09% | 30.30M |
| AXJL | 57.50 | -0.53 | -0.91% | |
| AXFN | 20.75 | +0.00 | +0.00% | |
| AXE | 58.43 | -0.07 | -0.12% | 1.932B |
| AXDI | 56.32 | +0.00 | +0.00% | |
| AXAS | 2.56 | -0.07 | -2.66% | 236.19M |
